Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Affirm Holdings Inc (AFRM) vs AstraZeneca plc (AZN) Price & Performance

Affirm Holdings IncTrade
AstraZeneca plcTrade

Price performance (Past 24H)

Key statistics

Affirm Holdings Inc vs AstraZeneca plc — how do they compare? Affirm Holdings Inc trades at $77.07 (market cap $25.30B), while AstraZeneca plc trades at $158.1 (market cap $250.84B). The key difference: AstraZeneca plc is far larger — about 9.9× Affirm Holdings Inc's market cap, and AstraZeneca plc pays a 1.97% dividend while Affirm Holdings Inc pays none. Which is the better fit depends on your goals.

AFRMAZN
Market Cap
$25.30B$250.84B
Sector
FinancialsHealth
52-Week High
$92.18$209.48
52-Week Low
$42.53$147.06
Enterprise Value
$31.91B$278.12B
Dividend Yield
1.97%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Affirm Holdings Inc

Affirm Holdings Inc offers a platform for digital and mobile first commerce. It comprises a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The firm generates its revenue from merchant networks, and through virtual card networks among others. Geographically, it generates a major share of its revenue from the United States.

Read more on AFRM

About AstraZeneca plc

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.

Read more on AZN